Clinical Trials on Alzheimer’s Disease (CTAD)

« back to

November 7, 2015

Clinical Trials on Alzheimer’s Disease (CTAD)

Clinical Trial in MCI Reducing Hippocampal Overactivity: HOPE4MCI
AgeneBio’s Michela Gallagher and Sharon Rosenzweig-Lipson to present in Barcelona on Saturday, November 7, 2015, at 11:45 am